IDEXX Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
IDEXX Laboratories has a total shareholder equity of $1.6B and total debt of $873.9M, which brings its debt-to-equity ratio to 54%. Its total assets and total liabilities are $3.4B and $1.7B respectively. IDEXX Laboratories's EBIT is $1.2B making its interest coverage ratio 62.3. It has cash and short-term investments of $308.6M.
Key information
54.0%
Debt to equity ratio
US$873.90m
Debt
| Interest coverage ratio | 62.3x |
| Cash | US$308.64m |
| Equity | US$1.62b |
| Total liabilities | US$1.73b |
| Total assets | US$3.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IDXX *'s short term assets ($1.4B) exceed its short term liabilities ($1.0B).
Long Term Liabilities: IDXX *'s short term assets ($1.4B) exceed its long term liabilities ($723.5M).
Debt to Equity History and Analysis
Debt Level: IDXX *'s net debt to equity ratio (34.9%) is considered satisfactory.
Reducing Debt: IDXX *'s debt to equity ratio has reduced from 456.8% to 54% over the past 5 years.
Debt Coverage: IDXX *'s debt is well covered by operating cash flow (104.9%).
Interest Coverage: IDXX *'s interest payments on its debt are well covered by EBIT (62.3x coverage).